Urofollitropin biosimilar(Ferring)

尿促卵泡素生物类似药 (Ferring)

Report date: 2026/05/13 20:02:10

Base Information

Drug NameUrofollitropin biosimilar(Ferring)
Drug Alias NameUrofollitropin - FerringBravelle
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionFollicle-stimulating hormone receptor agonists
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsInfertility, FemaleInfertility
Global Approved IndicationsInfertility
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2002/05/06
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesFerring Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFerring GmbhFerring Arzneimittel GmbhFerring International Center Sa +[4] 
Inactive CompaniesFerring BvFerring Pharmaceuticals Ltd
Active IndicationsInfertility, Female
Inactive IndicationsInfertility

Other Information

ATC CodeN/A
Related LinksN/A